Previous Article | Next Article ![]()
Clinical and Diagnostic Laboratory Immunology, Jan 1995, 53-56, Vol 2, No. 1
K Kimura, E Isogai, H Isogai, T Nishikawa, T Masuzawa, K Yoshikawa, S Kotake, S Ohno and N Fujii
We studied 93 patients with unclassified uveitis from two regions in Japan
(Hokkaido and Kanagawa) to assess the contribution of Borrelia species to
this condition. The seroprevalence of antibody to Borrelia species was
higher in patients from Hokkaido than in those from Kanagawa. The
unclassified uveitis of seropositive patients was probably a complication
of Lyme borreliosis since (i) the antibody titers were as high as those in
clinically diagnosed Lyme disease patients, (ii) healthy controls from
Hokkaido showed low seroprevalence in contrast with unclassified uveitis
patients from Hokkaido, and (iii) the reaction pattern of antibodies in
sera from patients with unclassified uveitis was the same as that in
patients with Lyme disease. This is the first report to reveal the high
risk of Lyme borreliosis in patients with unclassified uveitis in regions
endemic for Lyme disease. In case of unclassified uveitis as well as in
cases of inflammatory disease of unknown origin, Lyme disease should be
taken into consideration, especially in regions in which Lyme diseases is
endemic, even if it is reported only in animals.
Copyright © 1995 by the American Society for Microbiology. All rights reserved.
Prevalence of antibodies against Borrelia species in patients with unclassified uveitis in regions in which Lyme disease is endemic and nonendemic
Department of Microbiology, Sapporo Medical University, Japan.
| Antimicrob. Agents Chemother. | Clin. Microbiol. Rev. | Infect. Immun. |
|---|---|---|
| J. Clin. Microbiol. | J. Virol. | ALL ASM JOURNALS |